STAZOLVI Trademark

Trademark Overview


On Monday, September 28, 2015, a trademark application was filed for STAZOLVI with the United States Patent and Trademark Office. The USPTO has given the STAZOLVI trademark a serial number of 79175636. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, August 25, 2016. This trademark is owned by Novartis AG. The STAZOLVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
stazolvi

General Information


Serial Number79175636
Word MarkSTAZOLVI
Filing DateMonday, September 28, 2015
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, August 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, August 25, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, October 6, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 25, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 25, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 5, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 5, 2017NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, October 16, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, October 15, 2016DEATH OF INTERNATIONAL REGISTRATION
Thursday, August 25, 2016ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, August 25, 2016ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, August 25, 2016OPPOSITION TERMINATED NO. 999999
Thursday, August 25, 2016OPPOSITION SUSTAINED NO. 999999
Monday, May 30, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 30, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 27, 2016REFUSAL PROCESSED BY IB
Friday, May 20, 2016OPPOSITION INSTITUTED NO. 999999
Thursday, May 12, 2016OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Thursday, May 12, 2016OPPOSITION NOTICE (IB REFUSAL) CREATED
Thursday, February 11, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 12, 2016PUBLISHED FOR OPPOSITION
Thursday, December 24, 2015NOTICE OF PUBLICATION
Monday, December 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 4, 2015ASSIGNED TO EXAMINER
Tuesday, November 17, 2015APPLICATION FILING RECEIPT MAILED
Thursday, November 12, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 10, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, November 7, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB